IL22 and graft versus host disease: Notably, the ability to secrete high amounts of IL-22 by NCRpos/ILC3 exerts a key role in the regeneration of the mucosal gut barrier after immune depletion following allo-HSCT, thus protecting from GvHD onset (92, 93).